Skip Navigation

This Article
Right arrow Full Text (PDF )
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (48)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Franken, D. R.
Right arrow Articles by Hodgen, G. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Franken, D. R.
Right arrow Articles by Hodgen, G. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 8, No. 8, pp. 1240-1244, 1993
© 1993 European Society of Human Reproduction and Embryology


research-article

Andrology: The ability of the hemizona assay to predict human fertilization in different and consecutive in-vitro fertilization cycles*

Daniel R. Franken1,2,4, Thinus F. Kruger1, Sergio Oehninger2, Charles C. Coddington2, Carl Lombard3, K. Smith1 and Gary D. Hodgen2

1Tygerberg Hospital, Reproductive Biology Unit, Department of Obstetrics and Gynaecology Tygerberg, 7505 South Africa 2The Jones Institute for Reproductive Medicine, Department of Obstetrics and Gynecology, Eastern Virginia Medical School 601 Colley Avenue, Norfolk, VA 23507, USA 3South African Medical Research Council, Institute of Biostatistics Parow, South Africa

Correspondence: 4To whom correspondence should be addressed at: Tygerberg Hospital, Reproductive Biology Unit, Department of Obstetrics and Gynaecology, Tygerberg, 7505, South Africa

The objective of this prospective study was to examine the ability of the hemizona assay (HZA) to predict fertilization outcome of mature, pre-ovulatory oocytes under in-vitro fertilization (IVF) conditions. Since a large number of patients were evaluated over a long period, the power of the HZA to prognosticate fertilization results in the same and subsequent (consecutive) IVF cycles of those same patients was assessed. For IVF, only metaphase II oocytes were used. For the HZA, both fresh oocytes donated by patients at the time of IVF and oocytes recovered from surgically removed ovarian tissue (and salt-stored) were used, and bisected by micromanipulation techniques. Matching hemizonae were co-incubated either with spermatozoa from the patient (test) or from a fertile man (control) for 4 h. The number of spermatozoa tightly bound to the zona was counted. Patients (n = 112) were divided into two groups based on HZA results (expressed as HZA index or HZI): HZI ≥ 30% (n = 72) and <30% (n = 40). The patients with HZI <30% had significantly lower fertilization rates in both the HZA—IVF cycle and in subsequent cycles compared to patients with HZI ≥30% (P < 0.03). Linear discriminant analysis indicated the HZA to have a sensitivity of 84%, and positive and negative predictive values of 85 and 70% respectively, for prediction of fertilization outcome in a total of 233 cycles. It was concluded that the HZA is a good predictor of fertilization rate in vitro, and can be used in the IVF setting to supply additional clinical information in malefactor patients.

Key words: in-vitro fertilization/zona pellucida binding

*Presented in part at the 47th Annual Meeting of the American Fertility Society, Orlando, FL, 21-24 October 1991.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
D.Y. Liu, M.L. Liu, and H.W.G. Baker
Enhancement of sperm-zona pellucida (ZP) binding capacity by activation of protein kinase A and C pathways in certain infertile men with defective sperm-ZP binding
Hum. Reprod., January 1, 2009; 24(1): 20 - 27.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C. Sifer, T. Sasportes, V. Barraud, C. Poncelet, J. Rudant, R. Porcher, I. Cedrin-Durnerin, B. Martin-Pont, J.N. Hugues, and J.P. Wolf
World Health Organization grade 'a' motility and zona-binding test accurately predict IVF outcome for mild male factor and unexplained infertilities
Hum. Reprod., October 1, 2005; 20(10): 2769 - 2775.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
K. L. Pixton, E. D. Deeks, F. M. Flesch, F. L.C. Moseley, L. Bjorndahl, P. R. Ashton, C. L.R. Barratt, and I. A. Brewis
Sperm proteome mapping of a patient who experienced failed fertilization at IVF reveals altered expression of at least 20 proteins compared with fertile donors: Case report
Hum. Reprod., June 1, 2004; 19(6): 1438 - 1447.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
D. Y. Liu, G. N. Clarke, M. Martic, C. Garrett, and H.W.G. Baker
Frequency of disordered zona pellucida (ZP)-induced acrosome reaction in infertile men with normal semen analysis and normal spermatozoa-ZP binding
Hum. Reprod., June 1, 2001; 16(6): 1185 - 1190.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
D.Y. Liu and H.W.G. Baker
Defective sperm-zona pellucida interaction: a major cause of failure of fertilization in clinical in-vitro fertilization
Hum. Reprod., March 1, 2000; 15(3): 702 - 708.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.